Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 11-20 of 2308


We Still Haven’t Found a Fountain of Youth in Our DNAby Brian AlexanderMIT Technology ReviewApril 21st, 2016The Cypher Genomics project has been attempting to identify genetic variants that contribute to longevity, but so far there's no smoking gun.
Scientists unveil the ‘most clever CRISPR gadget’ so farby Sharon BegleySTATApril 20th, 2016A new "base editing" method attempts to switch out individual letters of DNA, but it's usefulness and precision is unclear.
More People Seek Genetic Testing, But There Aren't Enough Counselorsby Todd BookmanNPRApril 18th, 2016The field of precision medicine is facing a bottleneck: "Who will actually interpret and provide those results to patients?"
CRISPR: Pursuit of profit poisons collaborationby Jacob S. SherkowNature April 13th, 2016Overzealous efforts to commercialize technology can damage science.
One Thing that Could Stop the Rise of Gene Editing: Insurance Companiesby Jason KoeblerMotherboard [VICE]April 12th, 2016If insurance companies refuse to cover potential new treatments involving gene editing, precision medicine might be limited to those who can afford the expense.
The trouble with paying for spermby Alana Cattapan & Françoise BaylisThe Star [Toronto]April 9th, 2016The so-called shortage of Canadian sperm is not about men being unwilling to donate without pay.
The Scientific Swap Meet Behind the Gene-Editing Boomby Antonio RegaladoMIT Technology ReviewApril 8th, 2016"Amazon.com for biological parts," AddGene non-profit in Cambridge ships CRISPR-Cas9 parts all over the world. “It dramatically sped up CRISPR adoption."
Stem cell agency okays $150 million ‘powerhouse’by David JensenCapitol WeeklyApril 8th, 2016California agency approved financing terms for a proposed public-private company hoped to accelerate the creation of long-sought stem cell therapies.
Yeast Infection Led to Removal of Transplanted Uterusby Denise GradyThe New York TimesApril 8th, 2016If a yeast infection spreads into the bloodstream, it can be extremely difficult to treat, and can be fatal because of the immune suppressants required for the organ transplant.
Google’s biotech venture hit by ethical concerns over deal with luxury clinicby Charles PillerSTATApril 7th, 2016Contract awarded is of unclear relevance to Baseline project, which aims to collect genetic, clinical data on 10,000 patients.
Displaying 11-20 of 2308  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760